Activation of Human Dendritic Cells Through CD40 Cross-linking

Overview

Journal J Exp Med

Specialties Allergy & Immunology
General Medicine

Date 1994 Oct 1

PMID 7523569

Citations 312

Authors

C Caux

C Massacrier

B Vanbervliet

B Dubois

C van Kooten

I Durand

J Banchereau

Affiliations

Soon will be listed here.

Abstract

Dendritic cells, the professional antigen-presenting cells (APC) involved in T cell priming, express CD40, a molecule which triggering plays a key role in B cell growth and differentiation as well as monocyte activation. Herein we demonstrate that dendritic Langerhans cells (D-Lc) generated by culturing cord blood CD34+ progenitor cells with granulocyte/macrophage colony-stimulating and tumor necrosis factor alpha (TNF-alpha) express functional CD40 at a density higher than that found on B cells. Culturing D-Lc on CD40-ligand (CD40L) transfected L cells allowed D-Lc survival as 50 +/- 15% of seeded cells were recovered after 4 d while only 5% survived over control L cells. CD40 activation induced important morphological changes with a reduction of cytoplasmic content and a remarkable increase of dendrite development as well as an altered phenotype. In particular, CD40 triggering induced maintenance of high levels of major histocompatibility complex class II antigens and upregulation of accessory molecules such as CD58, CD80 (B7-1) and CD86 (B7-2). CD40 engagement also seems to turn on D-Lc maturation as illustrated by upregulation of CD25, a molecule usually expressed on interdigitating dendritic cells of secondary lymphoid organs. Finally, CD40 activated D-Lc secreted a limited set of cytokines (TNF-alpha, IL-8, and macrophage inflammatory protein 1 alpha [MIP-1 alpha]) whereas a similar activation induced elutriated monocytes to secrete IL-1 alpha, IL-1 beta, IL-6, IL-8, IL-10, TNF-alpha, and MIP-1 alpha. As D-Lc activated T cells upregulated CD40L, it is likely that CD40 activation of D-Lc observed herein with a fibroblast cell line stably expressing CD40L, mimics physiological interactions between dendritic cells and T cells.

Citing Articles

Dendritic cell maturation in cancer.

Moon C, Belabed M, Park M, Mattiuz R, Puleston D, Merad M Nat Rev Cancer. 2025; .

PMID: 39920276 DOI: 10.1038/s41568-024-00787-3.

Safety and tolerability of tegoprubart in patients with amyotrophic lateral sclerosis: A Phase 2A clinical trial.

Perrin S, Ladha S, Maragakis N, Rivner M, Katz J, Genge A PLoS Med. 2024; 21(10):e1004469.

PMID: 39480764 PMC: 11527214. DOI: 10.1371/journal.pmed.1004469.

Pathomics models for CD40LG expression and prognosis prediction in glioblastoma.

Li W, Xiao J, Zhang C, Di X, Yao J, Li X Sci Rep. 2024; 14(1):24350.

PMID: 39420038 PMC: 11487080. DOI: 10.1038/s41598-024-75018-8.

A phase 1 study of the CD40 agonist MEDI5083 in combination with durvalumab in patients with advanced solid tumors.

Tran B, Voskoboynik M, Bendell J, Gutierrez M, Lemech C, Day D Immunotherapy. 2024; 16(11):759-774.

PMID: 39264730 PMC: 11421296. DOI: 10.1080/1750743X.2024.2359359.

Development of pharmacological immunoregulatory anti-cancer therapeutics: current mechanistic studies and clinical opportunities.

Yin N, Li X, Zhang X, Xue S, Cao Y, Niedermann G Signal Transduct Target Ther. 2024; 9(1):126.

PMID: 38773064 PMC: 11109181. DOI: 10.1038/s41392-024-01826-z.

References

Macchia D, Almerigogna F, Parronchi P, RAVINA A, Maggi E, Romagnani S . Membrane tumour necrosis factor-alpha is involved in the polyclonal B-cell activation induced by HIV-infected human T cells. Nature. 1993; 363(6428):464-6. DOI: 10.1038/363464a0. View

Aversa G, Punnonen J, De Vries J . The 26-kD transmembrane form of tumor necrosis factor alpha on activated CD4+ T cell clones provides a costimulatory signal for human B cell activation. J Exp Med. 1993; 177(6):1575-85. PMC: 2191054. DOI: 10.1084/jem.177.6.1575. View

Alderson M, Armitage R, Tough T, Strockbine L, Fanslow W, Spriggs M . CD40 expression by human monocytes: regulation by cytokines and activation of monocytes by the ligand for CD40. J Exp Med. 1993; 178(2):669-74. PMC: 2191134. DOI: 10.1084/jem.178.2.669. View

ODoherty U, Steinman R, Peng M, Cameron P, Gezelter S, Kopeloff I . Dendritic cells freshly isolated from human blood express CD4 and mature into typical immunostimulatory dendritic cells after culture in monocyte-conditioned medium. J Exp Med. 1993; 178(3):1067-76. PMC: 2191184. DOI: 10.1084/jem.178.3.1067. View

Gauchat J, Henchoz S, Mazzei G, Aubry J, Brunner T, Blasey H . Induction of human IgE synthesis in B cells by mast cells and basophils. Nature. 1993; 365(6444):340-3. DOI: 10.1038/365340a0. View

Stutman O . Immune functions of tumor necrosis factor. I. Tumor necrosis factor induces apoptosis of mouse thymocytes and can also stimulate or inhibit IL-6-induced proliferation depending on the concentration of mitogenic costimulation. J Immunol. 1993; 151(8):3999-4012. View

van den Eertwegh A, Noelle R, Roy M, Shepherd D, Aruffo A, Ledbetter J . In vivo CD40-gp39 interactions are essential for thymus-dependent humoral immunity. I. In vivo expression of CD40 ligand, cytokines, and antibody production delineates sites of cognate T-B cell interactions. J Exp Med. 1993; 178(5):1555-65. PMC: 2191254. DOI: 10.1084/jem.178.5.1555. View

Foy T, Shepherd D, Durie F, Aruffo A, Ledbetter J, Noelle R . In vivo CD40-gp39 interactions are essential for thymus-dependent humoral immunity. II. Prolonged suppression of the humoral immune response by an antibody to the ligand for CD40, gp39. J Exp Med. 1993; 178(5):1567-75. PMC: 2191245. DOI: 10.1084/jem.178.5.1567. View

Spriggs M, Fanslow W, Armitage R, Belmont J . The biology of the human ligand for CD40. J Clin Immunol. 1993; 13(6):373-80. DOI: 10.1007/BF00920012. View

10.

Briere F, Servet-Delprat C, Bridon J, Saint-Remy J, Banchereau J . Human interleukin 10 induces naive surface immunoglobulin D+ (sIgD+) B cells to secrete IgG1 and IgG3. J Exp Med. 1994; 179(2):757-62. PMC: 2191366. DOI: 10.1084/jem.179.2.757. View

11.

Cayabyab M, Phillips J, Lanier L . CD40 preferentially costimulates activation of CD4+ T lymphocytes. J Immunol. 1994; 152(4):1523-31. View

12.

van Kooten C, Gaillard C, Galizzi J, Hermann P, Fossiez F, Banchereau J . B cells regulate expression of CD40 ligand on activated T cells by lowering the mRNA level and through the release of soluble CD40. Eur J Immunol. 1994; 24(4):787-92. DOI: 10.1002/eji.1830240402. View

13.

Banchereau J, Bazan F, Blanchard D, Briere F, Galizzi J, van Kooten C . The CD40 antigen and its ligand. Annu Rev Immunol. 1994; 12:881-922. DOI: 10.1146/annurev.iy.12.040194.004313. View

14.

Clark E, Ledbetter J . Activation of human B cells mediated through two distinct cell surface differentiation antigens, Bp35 and Bp50. Proc Natl Acad Sci U S A. 1986; 83(12):4494-8. PMC: 323760. DOI: 10.1073/pnas.83.12.4494. View

15.

Stamenkovic I, Clark E, Seed B . A B-lymphocyte activation molecule related to the nerve growth factor receptor and induced by cytokines in carcinomas. EMBO J. 1989; 8(5):1403-10. PMC: 400967. DOI: 10.1002/j.1460-2075.1989.tb03521.x. View

16.

Valle A, Zuber C, Defrance T, Djossou O, de Rie M, Banchereau J . Activation of human B lymphocytes through CD40 and interleukin 4. Eur J Immunol. 1989; 19(8):1463-7. DOI: 10.1002/eji.1830190818. View

17.

Romani N, Lenz A, Glassel H, STOSSEL H, Stanzl U, Majdic O . Cultured human Langerhans cells resemble lymphoid dendritic cells in phenotype and function. J Invest Dermatol. 1989; 93(5):600-9. DOI: 10.1111/1523-1747.ep12319727. View

18.

Teunissen M, Wormmeester J, Krieg S, Peters P, Vogels I, Kapsenberg M . Human epidermal Langerhans cells undergo profound morphologic and phenotypical changes during in vitro culture. J Invest Dermatol. 1990; 94(2):166-73. DOI: 10.1111/1523-1747.ep12874439. View

19.

Valle A, Garrone P, Yssel H, Bonnefoy J, Freedman A, Freeman G . mAb 104, a new monoclonal antibody, recognizes the B7 antigen that is expressed on activated B cells and HTLV-1-transformed T cells. Immunology. 1990; 69(4):531-5. PMC: 1385624. View

20.

Caux C, Saeland S, Favre C, Duvert V, Mannoni P, Banchereau J . Tumor necrosis factor-alpha strongly potentiates interleukin-3 and granulocyte-macrophage colony-stimulating factor-induced proliferation of human CD34+ hematopoietic progenitor cells. Blood. 1990; 75(12):2292-8. View